Predictive factors for survival of patients with inoperable malignant distal biliary strictures: A practical management guideline

Gut

Volumn 42, Issue 1, 1998, Pages 76-80

  Prat, F ^a   Chapat, O ^a   Ducot, B ^a   Ponchon, T ^b   Fritsch, J ^a   Choury, A D ^a   Pelletier, G ^a   Buffet, C ^a  

^a BICÊTRE HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Biliary tract cancer; Endoscopic retrograde cholangiopancreatography; Palliative treatment; Pancreatic cancer; Prognostic factors; Stents

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 0031971419     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.1.76     Document Type: Article

References (27)

1. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-303.
2. Sarr MG, Cameron JL. Surgical palliation of unresectable carcinoma of the pancreas. World J Surg 1984;8:906-18.
3. Cotton PB, Schmidt C. Quality of life in palliative management of malignant obstructive jaundice. Scand J Gastroenterol 1993;28(suppl):44-6.
4. Speer AG, Cotton PB, Russel RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;ii:57-62.
5. Smith AC, Dowsett JF, Russel RCG, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical by-pass in malignant low bile duct obstruction. Lancet 1994;344:1655-60.
6. Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988;75:1166-8.
7. Andersen JR, Sörensen SM, Kruse A, Rokkjaer M, Matsen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30:1132-5.
8. Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340:1488-92.
9. Knyrim K, Wagner HJ, Pausch J, Vabil N. A prospective randomized controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993;25: 207-12.
10. Cotton PB. Metallic mesh stents. Is the expanse worth the expense? Endoscopy 1992;24:421-3.
11. Prat F, Chapat O, Ponchon T, et al. Endoscopic palliation of malignant biliary strictures: results of a prospective randomized study [abstract]. Endoscopy 1996;28:S37.
12. Eastern Cooperative Oncology Group. In: WHO handbook for reporting results of cancer treatment. Geneva: World Health Organisation, 1979.
13. Keats AS. The ASA classification of physical status. A recapitulation. Anesthesiology 1978;49:233-6.
14. Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35:467-70.
15. Buffet C, Couderc T, Fritsch J, et al. Traitement palliatif par endoprothèse des ictères par obstacle tumoral sous-hilaire. Gastroenterol Clin Biol 1993;17:629-35.
16. van den Bosch RP, van der Schelling GP, Klinkenbijl JHG, Mulder PG, van Blankenstein M, Jeekel J. Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg 1994;219:18-24.
17. O'Brien S, Hatfield ARW, Craig PI, Williams SP. A three-year follow-up of self-expanding metal stents in the endoscopic palliation of long term survivors with malignant biliary obstruction. Gut 1995;36:618-21.
18. De Wys WD. Weight loss and nutritional abnormalities in cancer patients: incidence, severity and significance. In: Calman KC, Fearon KC, eds. Nutritional support for the cancer patient. London: Balliere Tindall, 1986:251-61.
19. Mannell A, Weiland LH, Van Heerden JA, Ilstrup DM. Factors influencing survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 1986;203:403-7.
20. Fearon KC, Preston T. Body composition in cancer cachexia. Infusion Therapy 1990;17(suppl 3):63-6.
21. Falconer JS, Fearon KC, Ross JA, et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995;755:2077-82.
22. Pereira-Lima LC, Jakobs R, Maier M, Benz C, Kohler B, Riemann JF. Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents. Am J Gastroenterol 1996;91:2179-84.
23. Nix GA, Dubbelman C, Wilson JH, Schütte HE, Jeekel J, Postema RR. Prognostic implications of the tumour diameter in carcinoma of the head of the pancreas. Cancer 1991; 67:529-35.
24. Tsuchiya R, Oribe T, Noda T. Size of the tumour and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 1985;80:459-62.
25. Petrek JA, Sandberg WA, Bean PK, Bradley EL. Can survival in pancreatic carcinoma be predicted by primary size or stage? Am Surg 1985;51:42-51.
26. Tsuchiya R, Noda T, Harada N, et al. Collective review of small carcinomas of the pancreas. Ann Surg 1986;203: 77-81.
27. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumour size is the primary prognostic indicator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996;223:147-53.